IgA Nephropathy and Significance of Immunostaining Data
author
Abstract:
This article doesn't have abstract
similar resources
significance of immunostaining data in iga nephropathy patients; current knowledge and new concepts.
letter to the editor
full textSignificance of immunostaining data in IgA nephropathy patients; current knowledge and new concepts.
Recently much attempts have been directed towards the significance of immunostaining findings and their correlations with clinical and morphologic lesions in IgA nephropathy (IgAN) patients. 1,2 However few investigations have been conducted on this subject. IgAN is the most common glomerulonephritis globally and is a leading cause of chronic kidney disease throughout the world. 2-6 As the most...
full textCorrelation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy.
BACKGROUND Oxford classification for IgA nephropathy (IgAN) did not include pattern of immunostaining in the analysis. OBJECTIVE The aim of this study is to determine the potential correlation between the immunostaining data and morphologic variables of Oxford classification (MEST) and various clinical and demographic data of patients with IgAN. PATIENTS AND METHODS The pathologic diagnosis...
full textSignificance of vasculopathy in IgA nephropathy patients with regard to Oxford classification and immunostaining findings: a single center experience
INTRODUCTION immunoglobulin A nephropathy is the most common primary glomerulonephritis around the world. It remains poorly understood whether vascular pathology plays an important role in the progression of IgAN. OBJECTIVES Since very few studies regarding vascular disorders in IgAN are published, we aimed to evaluate the role of vascular disease in a group of IgAN patients, especially with ...
full textMy Resources
Journal title
volume 10 issue 4
pages 267- 269
publication date 2013-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023